Area-under-the-Curve-Based Mycophenolate Mofetil Dosage May Contribute to Decrease the Incidence of Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients.
graft-versus-host disease
hematopoietic stem cell transplantation
mycophenolate mofetil
pediatric patients
therapeutic drug monitoring
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 Jan 2021
21 Jan 2021
Historique:
received:
18
11
2020
revised:
07
01
2021
accepted:
17
01
2021
entrez:
26
1
2021
pubmed:
27
1
2021
medline:
27
1
2021
Statut:
epublish
Résumé
Acute graft-versus-host disease (GvHD) remains the second leading cause of death, after disease relapse, in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The medical records of 112 pediatric patients who underwent allo-HSCT from matched unrelated and haploidentical donors were analyzed. Patients were divided into two groups, according to the GvHD prophylactic regimen used. In the control group, GvHD prophylaxis consisted of cyclosporine A (CsA) and methotrexate (MTX) or CsA and mycophenolate mofetil (MMF) at a standard daily dose of 30 mg/kg. All subjects in the study group received tacrolimus (FK506) and MMF. In this group, MMF was subjected to therapeutic drug monitoring (TDM) through mycophenolic acid (MPA) area under the curve AUC
Identifiants
pubmed: 33494356
pii: jcm10030406
doi: 10.3390/jcm10030406
pmc: PMC7865591
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Bone Marrow Transplant. 2008 Jul;42(2):113-20
pubmed: 18362900
Biol Blood Marrow Transplant. 2010 Mar;16(3):333-43
pubmed: 19835971
J Immunother Cancer. 2020 Oct;8(2):
pubmed: 33077513
Clin Transplant. 2001 Jun;15(3):176-84
pubmed: 11389708
N Engl J Med. 1979 May 10;300(19):1068-73
pubmed: 34792
J Clin Pharmacol. 2012 Nov;52(11):1665-75
pubmed: 22110162
Biol Blood Marrow Transplant. 2016 Apr;22(4):682-689
pubmed: 26740371
Clin Biochem. 2000 Apr;33(3):203-8
pubmed: 10913519
Int J Hematol. 2012 Jul;96(1):10-25
pubmed: 22592321
Int J Hematol. 2008 Jul;88(1):104-110
pubmed: 18473127
J Clin Pharmacol. 2000 Jun;40(6):624-33
pubmed: 10868313
N Engl J Med. 1986 Mar 20;314(12):729-35
pubmed: 3513012
Kidney Int. 2010 Jul;78(1):79-88
pubmed: 20375992
Cochrane Database Syst Rev. 2014 Jul 25;(7):CD010280
pubmed: 25061777
Clin Pharmacokinet. 2007;46(1):13-58
pubmed: 17201457
Eur J Drug Metab Pharmacokinet. 2017 Apr;42(2):183-189
pubmed: 27677732
Am J Transplant. 2005 May;5(5):987-94
pubmed: 15816878
Ther Drug Monit. 2006 Oct;28(5):623-31
pubmed: 17038876
Eur J Haematol. 2014 Dec;93(6):509-15
pubmed: 24889859
Clin Transplant. 2011 Mar-Apr;25(2):222-7
pubmed: 20201951
Ther Drug Monit. 2001 Aug;23(4):305-15
pubmed: 11477311
Leuk Res. 2014 Mar;38(3):352-60
pubmed: 24418750
Adv Ther. 2017 May;34(5):1184-1199
pubmed: 28429246
Orphanet J Rare Dis. 2007 Sep 04;2:35
pubmed: 17784964